Investment

Details

Screening Program
  • RFP Year
    2017
  • Awarded Amount
    $99,986
  • Disease
    Tuberculosis
  • Intervention
    Drug
  • Development Stage
    Hit Identification
  • Collaboration Partners
    Astellas Pharma Inc., The Global Alliance for TB Drug Development